A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lenalidomide
Related studies linked through entity extraction aliases.
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Status
- RECRUITING
- Phase
- PHASE3
A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
- Status
- RECRUITING
- Phase
- PHASE2
Immunomodulators on HIV-1 Reservoir
- Status
- UNKNOWN
- Phase
- PHASE4
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Status
- RECRUITING
- Phase
- PHASE3
NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE3
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- N/A